Hepatitis A susceptibility parallels high COVID-19 mortality

Hepatitis A susceptibility parallels high COVID-19 mortality

Background/aim:COVID-19 has become the biggest health problem of this century. It has been hypothesized that immunity against hepatitis A virus (HAV) may provide protection from COVID- 19. Materials and methods: As of 10June 2020, the infection had spread to 213 countries, with 7.3 million people infected and 413,733 dead. This data was combined with the World Health Organization susceptibility classification on the worldwide prevalence of HAV, and the relationship between HAV susceptibility and COVID-19 mortality were analyzed. Results: When the data from 213 countries were analyzed, it was found that there was a significant increasing trend in COVID-19 mortality rates by HAV susceptibility (P

___

  • 1. Sarialioglu F, Belen Apak FB, Haberal M. Can hepatitis A vaccine provide protection against COVID-19? Experimental and Clinical Transplantation 2020; 18 (2): 141‐143. doi: 10.6002/ect.2020.0109
  • 2. Jacobsen KH. The global prevalence of hepatitis A virus infection and susceptibility: a systematic review. Report number: WHO/IVB/10.01. Geneva, Switzerland: World Health Organization; 2009.
  • 3. Sakurai A, Sasaki T, Kato S, Hayashi M, Tsuzuki SI et al. Natural history of asymptomatic SARS-CoV-2 infection. The New England Journal of Medicine 2020; 383: 885-886. doi: 10.1056/NEJMc2013020
  • 4. Nelson NP. Travel related infectious diseases- hepatitis A. In: Brunette GW, Nemhauser JB (editors). Centers for Disease Control and Prevention. CDC Yellow Book 2020: Health Information for International Travel. New York, NY, USA: Oxford University Press; 2017.
Turkish Journal of Medical Sciences-Cover
  • ISSN: 1300-0144
  • Yayın Aralığı: Yılda 6 Sayı
  • Yayıncı: TÜBİTAK
Sayıdaki Diğer Makaleler

How does rerupture affect sleep and quality of life in patients undergoing arthroscopic rotator cuff repair?

İzzet BİNGÖL, Vedat BİÇİCİ

The prognostic value of serum levels of a proliferation-inducing ligand (APRIL) in treatment-naïve patients with chronic lymphocytic leukemia

Muhlis Cem AR, Teoman SOYSAL, Ayşe SALİHOĞLU, Hafize UZUN, Zafer BAŞLAR, Tuğrul ELVERDİ, Ahmet Emre EŞKAZAN, Şeniz ÖNGÖREN, Sinem Nihal ESATOĞLU, Dilek KESKİN, Yıldız AYDIN

act of low molecular weight heparin administration on the clinical course of the COVID-19 disease

Fikret KANAT, Baykal TÜLEK, Recai ERGÜN, Burcu YORMAZ, Dilek ERGÜN, Uğur ARSLAN

Efficacy of the in vitro splitting of human preimplantation embryos from ART programs

Marjan OMIDI, Mohammad Ali KHALILI, Azam AGHA-RAHIMI, Stefania A. NOTTOLA, Fatemeh ANBARI, Azita FARAMARZI, Maria Grazia PALMERINI

Diagnostic efficacy of apparent diffusion coefficient measurements in differentiation of malignant intra-axial brain tumors

İlker EYÜBOĞLU, Serdar ASLAN, İsmet Miraç ÇAKIR, Ahmet SARI

Magnetic resonance imaging histogram analysis of corpus callosum in a functional neurological disorder

Sema BAYKARA, Murad ATMACA, Osman MERMİ, Hanefi YILDIRIM, Murat BAYKARA

What is the predictive value of preoperative CA 125 level on the survival rate of type 1 endometrial cancer?

Fatih KÖSE, Gülşen DOĞAN DURDAĞ, Şafak YILMAZ BARAN, Seda YÜKSEL ŞİMŞEK, Songül ALEMDAROĞLU, Filiz AKA BOLAT, Hüsnü ÇELİK

Stereological and histopathological evaluation of the effect of Thymoquinone on peridural fibrosis following laminectomy in rats

Dursun TÜRKÖZ, Mehmet Emin ÖNGER, Aytaç TÜRKÖZ, Enis KURUOĞLU

Do initial hematologic indices predict the severity of COVID-19 patients?

Nizameddin KOCA, Yasemin ÜSTÜNDAĞ, Abdullah ŞİMŞEK, Hülya PARILDAR, Kağan HUYSAL, Ali ASAN, Burcu Dalyan CİLO, Halil Erkan SAYAN

Turkish reliability and validity study of the medical outcomes study (MOS) sleep scale in patients with obstructive sleep apnea

Sinan YETKİN, Bülent Devrim AKÇAY, Duygu AKÇAY